Clinical trials
Phase 4 Lung Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 5 |
| Recruiting | 4 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CSA Medical, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Fox Chase Cancer Center | 1 |
| Galvanize Therapeutics, Inc. | 1 |
| George Washington University | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Lisa Sanderson Cox, PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 21 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Head and Neck Neoplasms | 5 |
| Carcinoma, Hepatocellular | 3 |
| Carcinoma, Renal Cell | 3 |
| Melanoma | 3 |
| Pancreatic Neoplasms | 3 |
| Esophageal Neoplasms | 2 |
| Hypopharyngeal Neoplasms | 2 |
| Kidney Neoplasms | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.